Blue Latitude Health’s consultancy is based on a rich vein of expert knowledge. Here you’ll find thought-provoking commentary, articles, and downloadable resources created by our consultants.
Explore our ideas and get a deeper understanding of the current and future trends in healthcare:
| 29th September 2015
With pharma in the midst of a patent cliff, portfolios of treatments are becoming more and more common, and the need for a clear co-positioning strategy has never been greater.
Head of Brand Strategy Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.
| 23rd September 2015
Recently, Blue Latitude Health worked with a global pharmaceutical brand to develop a strategy for dealing with the introduction of biosimilars to the market. Their product, a treatment in the gastroenterology therapy area, had recently come off patent and a biosimilar was about to launch. Strategy Consultant Mark Assenti talks through three key points for developing a strategy to tackle biosimilars.
| 15th September 2015
Traditionally, we look at the environment of the patient with the patient in the centre of a circle of healthcare professionals, carers, institutions or clinics, and sometimes services. Elisa del Galdo takes us through a better way to look at patient-centricity: with the patient’s journey at the centre.
| 22nd July 2015
Recently, we’ve worked across multiple brands in oncology on launch and pre-launch strategy, which raises a unique set of challenges in a competitive and highly regulated market. Matt Bolton, Head of Commercial, takes us through the three key points to keep in mind when developing a pharmaceutical pre-launch positioning strategy.
| 2nd July 2015
Head of Customer Experience Elisa del Galdo talks through the key considerations for pharma companies when designing and delivering digital patient services from a customer experience perspective.
| 25th June 2015
The healthcare industry has traditionally been slow to adopt new technologies. This may be due to patient ability or an industry aversion to early adoption, but there is another, often overlooked option available: using existing, established technology to improve patient outcomes through innovative services. Account Executive Will Taylor talks us through a case study in applying established technology to healthcare problems in an innovative way.
| 24th June 2015
Director and Head of Commercial Simon takes us through some of the key themes of the Financial Times Digital Health Summit in London, outlining and expanding on where we feel the industry is heading as we get closer to the ‘digital health revolution’.
| 16th June 2015
For Blue Latitude Health, the discussion and speculation around the future of the NHS begs the question: what is the role of Pharma in facilitating the deployment of digital transformation? Senior Associate Consultant Angela Lopes has written a thought leadership piece for Blue Latitude Health to tackle this question, based on a piece of research conducted with Consultant David and US VP James from the Strategy team.
| 12th June 2015
Blue Latitude Health sent two of our consultants to Chicago to attend ASCO 15, a key annual meeting for oncology specialists that brings over 30,000 delegates together to talk about innovations and progress in the field. David takes us through the highlights of the event and his take on the exciting developments that came out of the conference.
| 28th May 2015
Following her previous piece on patient medical non-adherence, Head of Customer Experience Elisa del Galdo takes a look at the different patient personas that emerge during the diagnosis and treatment pathway. Download her sketchnote of the three personas and read about how to design services for unengaged patients.